SCHEMBL4053479

SCHEMBL4053479

Cn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)NCCOc4ccccn4)cc3)cc2n(CCCO)c1=O

nearest known ligand 0.79

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 20/20 0.79
ADORA3 P0DMS8 8/20 0.79
ADORA1 P30542 8/20 0.79
ADORA2A P29274 10/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4050288 0.91 ADORA2B (0.83) ADORA2BADORA3ADORA1ADORA2A
SCHEMBL4231377 0.91 ADORA2B (0.84) ADORA2BADORA3ADORA1ADORA2A
SCHEMBL4053822 0.89 ADORA2B (1.00) ADORA2BADORA3ADORA1ADORA2A
SCHEMBL4054001 0.88 ADORA2B (0.81) ADORA2BADORA3ADORA1ADORA2A
SCHEMBL4050195 0.85 ADORA2B (0.83) ADORA2BADORA3ADORA1ADORA2A
SCHEMBL4051646 0.79 ADORA2B (0.79) ADORA2BADORA3ADORA1ADORA2A
SCHEMBL4050752 0.79 ADORA2B (0.88) ADORA2BADORA3ADORA1ADORA2A
SCHEMBL4714666 0.78 ADORA2B (0.80) ADORA2BADORA3ADORA1ADORA2A
SCHEMBL4051999 0.78 ADORA2B (0.80) ADORA2BADORA3ADORA1ADORA2A
SCHEMBL4059708 0.78 ADORA2B (0.79) ADORA2BADORA3ADORA1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7504398-B2 potent and selective antagonists of adenosine receptors; Parkinson's disease, asthma, allergies, inflammation, atherosclerosis, hypertension, gastrointestinal disorders, cell proliferation and autoimmune diseases; sulfonamidation LABORATORIOS ALMIRALL S.A. (ES) 2009-03-17 US disclosed
EP-1492793-B1 NEW-4-(PYRROLOPYRIMIDIN-6-YL)BENZENESULPHONAMIDE DERIVATIVES ALMIRALL LAB (ES) 2008-01-16 EP disclosed